Authorizes the commissioner of health to establish standards for approval of onsite overdose response services; requires nightlife establishments, sporting or event centers, theaters, concert venues, and amusement parks to maintain a supply of opioid antagonists; provides that emergency use of opioid antagonist is covered by good Samaritan law.
This bill simplifies enrollment and recertification for New York Medicaid recipients needing long-term care. It automatically assigns people requiring community-based long-term care for over 120 days to a managed care plan (based on prior care workers, quality, and location), unless they choose otherwise. It also allows certain groups - like those in managed long-term care plans, receiving personal care services, or getting fixed Social Security income - to recertify automatically without resubmitting resource documentation, using "attestation" instead. These changes aim to reduce administrative burdens for both recipients and the state.
This bill requires healthcare providers found guilty of serious misconduct - such as sexual abuse, drug abuse harming patients, or inappropriate prescribing resulting in harm - to provide written disclosure to current and new patients before treatment. The disclosure must detail their disciplinary status, penalties, practice restrictions, and resources for further information. Providers must obtain a signed copy of this disclosure before the first patient visit or treatment. Exceptions apply in emergencies or if a patient is incapacitated and their representative isn’t available. The law applies to probationary orders issued on or after January 1, 2026.
Relates to establishing distinctive "Alzheimer's Awareness" license plates; provides that the funding for such be deposited in the "Alzheimer's disease assistance fund".
This bill establishes the "Sickle Cell Treatment Act" to improve care for sickle cell disease patients in New York. It designates five "centers for excellence" (with two north of Putnam/Orange counties) and ten outpatient treatment centers based on patient populations, providing each center with annual funding ($500,000 for excellence centers, $250,000 for outpatient centers) to support specialized care, research, and equipment. The bill also modifies opioid prescribing rules to exempt sickle cell disease patients from a three-month opioid limit, ensuring they can receive necessary pain management without restrictive barriers. These changes directly affect hospitals designated as centers, sickle cell patients requiring specialized care, and healthcare providers managing chronic pain.
This bill (S 4955) sets new standards for how New York's Medicaid Inspector General audits and reviews payments to healthcare providers. It requires the Inspector General to follow specific protocols when checking claims, cost reports, or payments, including providing providers access to applicable standards before audits begin. Key provisions include mandating detailed explanations in audit reports, considering factors like whether errors were minor clerical mistakes (e.g., transposed codes), and limiting recoupment for isolated errors. The bill directly affects Medicaid providers who receive state medical assistance payments, ensuring audits are transparent, fair, and based on clear, documented procedures.
This bill (S 6551) requires health insurance plans in New York to cover image-guided breast biopsies when recommended by a physician based on nationally recognized clinical guidelines. It directly affects patients seeking breast cancer screening and diagnosis, as well as insurance companies that must now include this specific procedure in mandatory coverage. The bill amends insurance law to explicitly add "image-guided breast biopsies" to the list of covered services alongside mammograms, ultrasounds, and MRI scans. Coverage applies only when the procedure aligns with evidence-based guidelines developed by independent medical organizations. The change takes effect January 1, 2026, for all new or renewed insurance policies.
Exempts any covered substance use disorder and mental health treatment services and all FDA approved medications for the treatment of substance use disorder, HIV, hepatitis C and mental health conditions, from all recipient restriction program coverage and payment restrictions.
Relates to the health, safety and human rights of incarcerated pregnant individuals, incarcerated birthing parents and their children; requires the commissioner of corrections and community supervision to establish rules and regulations relating to conditions in institutions and correctional facilities and the treatment and care of birthing parents in such institutions and facilities.
Includes implants, replacement dental prosthetic appliances, crowns and root canals as medically necessary dental care and services for coverage under the Medicaid program if a qualified dentist authorizes the procedures.
